Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 16 | 2019 | 298 | 1.850 |
Why?
|
| Coronary Artery Disease | 18 | 2019 | 887 | 1.830 |
Why?
|
| Stents | 13 | 2015 | 789 | 1.580 |
Why?
|
| Drug-Eluting Stents | 9 | 2017 | 67 | 1.390 |
Why?
|
| Iran | 19 | 2020 | 93 | 0.880 |
Why?
|
| Angioplasty, Balloon, Coronary | 10 | 2019 | 161 | 0.880 |
Why?
|
| Carotid Stenosis | 3 | 2013 | 106 | 0.830 |
Why?
|
| Coronary Angiography | 16 | 2024 | 449 | 0.820 |
Why?
|
| Postoperative Complications | 6 | 2019 | 3124 | 0.750 |
Why?
|
| Angioplasty | 2 | 2013 | 63 | 0.750 |
Why?
|
| ST Elevation Myocardial Infarction | 3 | 2020 | 116 | 0.680 |
Why?
|
| Sirolimus | 4 | 2016 | 230 | 0.610 |
Why?
|
| Everolimus | 2 | 2016 | 49 | 0.580 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2016 | 266 | 0.560 |
Why?
|
| Microvascular Angina | 1 | 2018 | 2 | 0.550 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2013 | 760 | 0.520 |
Why?
|
| Treatment Outcome | 30 | 2019 | 12850 | 0.520 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 91 | 0.510 |
Why?
|
| Coronary Artery Bypass | 3 | 2017 | 514 | 0.490 |
Why?
|
| Tricuspid Valve | 1 | 2016 | 58 | 0.480 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2016 | 60 | 0.480 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2016 | 61 | 0.470 |
Why?
|
| Absorbable Implants | 1 | 2016 | 24 | 0.470 |
Why?
|
| Polymers | 1 | 2016 | 103 | 0.450 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 162 | 0.440 |
Why?
|
| Follow-Up Studies | 14 | 2019 | 5184 | 0.420 |
Why?
|
| Middle Aged | 36 | 2026 | 28420 | 0.420 |
Why?
|
| Registries | 12 | 2026 | 1614 | 0.420 |
Why?
|
| Aorta, Thoracic | 2 | 2016 | 526 | 0.400 |
Why?
|
| Coronary Stenosis | 4 | 2008 | 78 | 0.400 |
Why?
|
| Electrocardiography | 3 | 2018 | 969 | 0.390 |
Why?
|
| Aortic Valve | 1 | 2016 | 455 | 0.390 |
Why?
|
| Coronary Restenosis | 4 | 2017 | 23 | 0.380 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 235 | 0.370 |
Why?
|
| Limb Salvage | 1 | 2013 | 155 | 0.360 |
Why?
|
| Aged | 24 | 2026 | 20897 | 0.350 |
Why?
|
| Aortic Coarctation | 1 | 2013 | 98 | 0.350 |
Why?
|
| Diabetes Complications | 1 | 2013 | 197 | 0.350 |
Why?
|
| Time Factors | 14 | 2019 | 6168 | 0.340 |
Why?
|
| Cardiovascular Diseases | 5 | 2019 | 2111 | 0.340 |
Why?
|
| Myocardial Infarction | 6 | 2013 | 998 | 0.330 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 962 | 0.320 |
Why?
|
| Diabetic Foot | 1 | 2013 | 171 | 0.320 |
Why?
|
| Coronary Disease | 2 | 2018 | 623 | 0.320 |
Why?
|
| Metals | 1 | 2010 | 70 | 0.310 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 2598 | 0.310 |
Why?
|
| Aortic Aneurysm | 1 | 2013 | 224 | 0.310 |
Why?
|
| Female | 40 | 2026 | 70546 | 0.300 |
Why?
|
| Cardiac Catheterization | 3 | 2024 | 628 | 0.300 |
Why?
|
| Male | 40 | 2026 | 64587 | 0.270 |
Why?
|
| Humans | 47 | 2026 | 130514 | 0.270 |
Why?
|
| Vascular Fistula | 1 | 2008 | 25 | 0.260 |
Why?
|
| Prospective Studies | 9 | 2018 | 6424 | 0.260 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2013 | 482 | 0.260 |
Why?
|
| Angioplasty, Balloon | 3 | 2018 | 122 | 0.250 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2007 | 10 | 0.250 |
Why?
|
| Risk Factors | 14 | 2026 | 11011 | 0.250 |
Why?
|
| Catheterization, Central Venous | 1 | 2008 | 143 | 0.250 |
Why?
|
| Prostheses and Implants | 1 | 2008 | 145 | 0.240 |
Why?
|
| Endarterectomy, Carotid | 1 | 2006 | 75 | 0.230 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2008 | 229 | 0.220 |
Why?
|
| Coronary Vessels | 4 | 2024 | 521 | 0.210 |
Why?
|
| Myocarditis | 1 | 2026 | 122 | 0.210 |
Why?
|
| Endovascular Procedures | 1 | 2013 | 791 | 0.210 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 888 | 0.210 |
Why?
|
| Aortography | 2 | 2016 | 154 | 0.210 |
Why?
|
| Prosthesis Design | 4 | 2017 | 633 | 0.210 |
Why?
|
| Risk Assessment | 7 | 2026 | 3687 | 0.210 |
Why?
|
| Cardiotoxicity | 1 | 2024 | 48 | 0.200 |
Why?
|
| Patient Selection | 2 | 2014 | 724 | 0.200 |
Why?
|
| Microcirculation | 1 | 2024 | 104 | 0.200 |
Why?
|
| Pulmonary Artery | 1 | 2007 | 434 | 0.190 |
Why?
|
| Coronary Occlusion | 2 | 2014 | 34 | 0.190 |
Why?
|
| Hospital Mortality | 5 | 2020 | 1059 | 0.190 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2007 | 279 | 0.190 |
Why?
|
| Proportional Hazards Models | 6 | 2019 | 1409 | 0.190 |
Why?
|
| Multivariate Analysis | 7 | 2018 | 1376 | 0.180 |
Why?
|
| Thrombolytic Therapy | 2 | 2015 | 191 | 0.170 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2013 | 41 | 0.160 |
Why?
|
| Retrospective Studies | 11 | 2026 | 17649 | 0.160 |
Why?
|
| Sodium Chloride | 2 | 2010 | 89 | 0.150 |
Why?
|
| Coronary Thrombosis | 1 | 2019 | 33 | 0.150 |
Why?
|
| Nanomedicine | 1 | 2019 | 29 | 0.150 |
Why?
|
| Sodium Bicarbonate | 2 | 2010 | 55 | 0.150 |
Why?
|
| Regenerative Medicine | 1 | 2019 | 37 | 0.150 |
Why?
|
| Troponin | 1 | 2019 | 69 | 0.150 |
Why?
|
| Infusions, Intravenous | 3 | 2016 | 531 | 0.150 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 3039 | 0.140 |
Why?
|
| Fluid Therapy | 2 | 2010 | 141 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2014 | 1069 | 0.140 |
Why?
|
| Exercise Test | 2 | 2018 | 239 | 0.140 |
Why?
|
| Cholecalciferol | 1 | 2018 | 20 | 0.140 |
Why?
|
| Dilatation, Pathologic | 1 | 2018 | 73 | 0.140 |
Why?
|
| Immunosuppressive Agents | 2 | 2016 | 653 | 0.140 |
Why?
|
| Survival Rate | 3 | 2019 | 2109 | 0.130 |
Why?
|
| Anticoagulants | 2 | 2015 | 601 | 0.130 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2017 | 19 | 0.130 |
Why?
|
| Disease-Free Survival | 4 | 2014 | 903 | 0.130 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 81 | 0.130 |
Why?
|
| Incidence | 4 | 2019 | 3336 | 0.130 |
Why?
|
| Chi-Square Distribution | 3 | 2014 | 562 | 0.130 |
Why?
|
| Diabetic Angiopathies | 1 | 2017 | 66 | 0.120 |
Why?
|
| Myocardial Revascularization | 1 | 2017 | 100 | 0.120 |
Why?
|
| Injections, Intra-Arterial | 1 | 2016 | 17 | 0.120 |
Why?
|
| Elective Surgical Procedures | 1 | 2017 | 161 | 0.120 |
Why?
|
| Vascular Grafting | 1 | 2016 | 51 | 0.120 |
Why?
|
| Contrast Media | 2 | 2010 | 476 | 0.120 |
Why?
|
| ROC Curve | 1 | 2018 | 613 | 0.120 |
Why?
|
| Myocardial Reperfusion | 1 | 2015 | 53 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2016 | 349 | 0.110 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2015 | 26 | 0.110 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 217 | 0.110 |
Why?
|
| Logistic Models | 6 | 2018 | 1796 | 0.110 |
Why?
|
| Adult | 10 | 2026 | 31115 | 0.110 |
Why?
|
| Cardiac Care Facilities | 2 | 2017 | 10 | 0.110 |
Why?
|
| Coronary Circulation | 2 | 2024 | 187 | 0.110 |
Why?
|
| Length of Stay | 1 | 2020 | 1412 | 0.110 |
Why?
|
| Comorbidity | 3 | 2020 | 1588 | 0.110 |
Why?
|
| Reoperation | 1 | 2017 | 815 | 0.100 |
Why?
|
| Crocus | 1 | 2013 | 1 | 0.100 |
Why?
|
| Fluoxetine | 1 | 2013 | 47 | 0.100 |
Why?
|
| Phytotherapy | 1 | 2013 | 46 | 0.100 |
Why?
|
| Paclitaxel | 2 | 2012 | 129 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2026 | 6772 | 0.090 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2013 | 113 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1874 | 0.090 |
Why?
|
| Product Labeling | 1 | 2012 | 4 | 0.090 |
Why?
|
| Age of Onset | 2 | 2017 | 591 | 0.090 |
Why?
|
| Medication Adherence | 1 | 2015 | 337 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 776 | 0.090 |
Why?
|
| Odds Ratio | 5 | 2017 | 1208 | 0.090 |
Why?
|
| Immunoglobulin Fragments | 1 | 2011 | 12 | 0.090 |
Why?
|
| Scorpion Venoms | 1 | 2011 | 14 | 0.090 |
Why?
|
| Antivenins | 1 | 2011 | 13 | 0.090 |
Why?
|
| Snake Bites | 1 | 2011 | 17 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2013 | 246 | 0.090 |
Why?
|
| Biomarkers | 4 | 2018 | 3365 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 787 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2013 | 319 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 852 | 0.080 |
Why?
|
| Blood Volume | 1 | 2010 | 73 | 0.080 |
Why?
|
| Hypertension | 2 | 2016 | 1352 | 0.080 |
Why?
|
| Acute Disease | 1 | 2013 | 1152 | 0.080 |
Why?
|
| Wound Healing | 1 | 2013 | 486 | 0.070 |
Why?
|
| Anxiety | 1 | 2016 | 1010 | 0.070 |
Why?
|
| Cohort Studies | 5 | 2019 | 5048 | 0.070 |
Why?
|
| Patient Dropouts | 1 | 2009 | 50 | 0.070 |
Why?
|
| Collagen Diseases | 1 | 2008 | 4 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 477 | 0.070 |
Why?
|
| Blood Coagulation Tests | 1 | 2008 | 65 | 0.070 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 96 | 0.070 |
Why?
|
| Heart Failure | 2 | 2019 | 2325 | 0.070 |
Why?
|
| Thrombophilia | 1 | 2008 | 41 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2012 | 1112 | 0.070 |
Why?
|
| Radiology, Interventional | 1 | 2008 | 31 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1161 | 0.070 |
Why?
|
| Young Adult | 2 | 2026 | 10034 | 0.060 |
Why?
|
| Insulin | 1 | 2012 | 1145 | 0.060 |
Why?
|
| Sex Factors | 3 | 2017 | 1348 | 0.060 |
Why?
|
| Stroke | 2 | 2013 | 1059 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 1457 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2011 | 761 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2009 | 462 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2010 | 475 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2008 | 540 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2061 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2009 | 514 | 0.050 |
Why?
|
| Depression | 1 | 2013 | 1316 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2009 | 494 | 0.050 |
Why?
|
| Prognosis | 2 | 2026 | 4866 | 0.050 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2024 | 54 | 0.050 |
Why?
|
| Double-Blind Method | 3 | 2013 | 1613 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2009 | 703 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2018 | 3351 | 0.040 |
Why?
|
| Hospitalization | 1 | 2008 | 1942 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2014 | 1243 | 0.040 |
Why?
|
| Age Factors | 2 | 2019 | 2818 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 421 | 0.030 |
Why?
|
| Creatinine | 2 | 2010 | 398 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2017 | 103 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2019 | 356 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 318 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 502 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 566 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1234 | 0.030 |
Why?
|
| Ticlopidine | 1 | 2015 | 28 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 1814 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2007 | 1480 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 3815 | 0.020 |
Why?
|
| Adolescent | 2 | 2008 | 20877 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2013 | 124 | 0.020 |
Why?
|
| Scorpions | 1 | 2011 | 5 | 0.020 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2011 | 21 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2011 | 59 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 59 | 0.020 |
Why?
|
| Respiratory System | 1 | 2011 | 95 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 87 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2192 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 409 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 573 | 0.020 |
Why?
|
| Edema | 1 | 2011 | 129 | 0.020 |
Why?
|
| Hypotonic Solutions | 1 | 2010 | 11 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2013 | 829 | 0.020 |
Why?
|
| Troponin T | 1 | 2011 | 257 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2010 | 54 | 0.020 |
Why?
|
| Iohexol | 1 | 2009 | 19 | 0.020 |
Why?
|
| Triiodobenzoic Acids | 1 | 2009 | 29 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 238 | 0.020 |
Why?
|
| Poland | 1 | 2009 | 18 | 0.020 |
Why?
|
| Neoplasms | 1 | 2024 | 2994 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2012 | 386 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 2692 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2011 | 485 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2008 | 270 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 278 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 650 | 0.020 |
Why?
|
| Thrombosis | 1 | 2012 | 498 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 1165 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2008 | 371 | 0.010 |
Why?
|
| Shock, Cardiogenic | 1 | 2007 | 176 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 1287 | 0.010 |
Why?
|
| Animals | 2 | 2019 | 33731 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 362 | 0.010 |
Why?
|
| Recurrence | 1 | 2007 | 1482 | 0.010 |
Why?
|